Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for STAA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Research and Development Expense (TTM) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 37.54M
March 31, 2026 37.84M
December 31, 2025 41.61M
September 30, 2025 44.61M
June 30, 2025 50.10M
March 31, 2025 54.07M
December 31, 2024 53.97M
September 30, 2024 52.80M
June 30, 2024 49.77M
March 31, 2024 47.47M
December 31, 2023 44.40M
September 30, 2023 43.32M
June 30, 2023 41.47M
March 31, 2023 38.35M
December 31, 2022 35.98M
September 30, 2022 35.26M
June 30, 2022 33.92M
March 31, 2022 33.54M
December 31, 2021 33.86M
September 30, 2021 33.75M
June 30, 2021 34.23M
March 31, 2021 33.28M
December 31, 2020 31.92M
September 30, 2020 30.37M
June 30, 2020 27.77M
Date Value
March 31, 2020 26.56M
December 31, 2019 25.30M
September 30, 2019 23.59M
June 30, 2019 23.01M
March 31, 2019 22.26M
December 31, 2018 21.66M
September 30, 2018 21.58M
June 30, 2018 20.44M
March 31, 2018 19.86M
December 31, 2017 19.60M
September 30, 2017 18.25M
June 30, 2017 18.28M
March 31, 2017 18.17M
December 31, 2016 20.29M
September 30, 2016 19.98M
June 30, 2016 19.21M
March 31, 2016 18.09M
December 31, 2015 14.76M
September 30, 2015 14.04M
June 30, 2015 13.50M
March 31, 2015 12.46M
December 31, 2014 12.36M
September 30, 2014 11.09M
June 30, 2014 9.638M
March 31, 2014 8.826M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Intuitive Surgical, Inc. 1.414B
Enovis Corp. 124.32M
Stryker Corp. 1.606B
Zimmer Biomet Holdings, Inc. 442.90M
Edwards Lifesciences Corp. 1.091B